ProfileGDS4718 / 233637_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 25% 16% 16% 22% 23% 22% 16% 25% 22% 22% 16% 23% 14% 20% 20% 21% 18% 27% 24% 35% 18% 20% 22% 25% 27% 18% 26% 33% 31% 21% 23% 17% 22% 21% 22% 18% 24% 18% 19% 22% 21% 20% 19% 20% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3519925
GSM549102patient 115, normal, homogenized [OPG study]4.0236716
GSM549104patient 119, normal, homogenized [OPG study]3.9820716
GSM549108patient 138, normal, homogenized [OPG study]4.2593422
GSM549119patient 077, normal, homogenized [OPG study]4.2623123
GSM549133patient 032, cancer, homogenized [OPG study]4.1587422
GSM549139patient 042, cancer, homogenized [OPG study]3.9887616
GSM549099patient 107, normal, homogenized [OPG study]4.3381525
GSM549109patient 139, normal, homogenized [OPG study]4.2559722
GSM549110patient 046, normal, homogenized [OPG study]4.2057722
GSM549114patient 063, normal, homogenized [OPG study]3.9811316
GSM549122patient 082, normal, homogenized [OPG study]4.252123
GSM549134patient 033, cancer, homogenized [OPG study]3.9136814
GSM549136patient 036, cancer, homogenized [OPG study]4.1065220
GSM549140patient 044, cancer, homogenized [OPG study]4.1219320
GSM549111patient 047, normal, homogenized [OPG study]4.1646221
GSM549113patient 057, normal, homogenized [OPG study]4.0303718
GSM549132patient 031, cancer, homogenized [OPG study]4.395327
GSM549137patient 038, cancer, homogenized [OPG study]4.2672524
GSM549142patient 047, cancer, homogenized [OPG study]4.8714835
GSM549100patient 110, normal, homogenized [OPG study]4.0627218
GSM549107patient 135, normal, homogenized [OPG study]4.1281720
GSM549115patient 068, normal, homogenized [OPG study]4.1703122
GSM549116patient 072, normal, homogenized [OPG study]4.3387925
GSM549120patient 078, normal, homogenized [OPG study]4.4012827
GSM549131patient 030, cancer, homogenized [OPG study]4.0338118
GSM549118patient 074, normal, homogenized [OPG study]4.3587626
GSM549129patient 027, cancer, homogenized [OPG study]4.6702933
GSM549123patient 088, normal, homogenized [OPG study]4.5688231
GSM549124patient 006, cancer, homogenized [OPG study]4.2049621
GSM549126patient 015, cancer, homogenized [OPG study]4.2528523
GSM549128patient 025, cancer, homogenized [OPG study]4.0119317
GSM549103patient 117, normal, homogenized [OPG study]4.267722
GSM549117patient 073, normal, homogenized [OPG study]4.1600121
GSM549138patient 041, cancer, homogenized [OPG study]4.1952622
GSM549141patient 045, cancer, homogenized [OPG study]4.0027118
GSM549130patient 028, cancer, homogenized [OPG study]4.3273624
GSM549101patient 111, normal, homogenized [OPG study]4.0627218
GSM549105patient 128, normal, homogenized [OPG study]4.1308919
GSM549106patient 134, normal, homogenized [OPG study]4.1849722
GSM549112patient 048, normal, homogenized [OPG study]4.1908121
GSM549125patient 011, cancer, homogenized [OPG study]4.1447520
GSM549127patient 024, cancer, homogenized [OPG study]4.0823319
GSM549135patient 035, cancer, homogenized [OPG study]4.1038120